Company Name: Mirna Therapeutics Inc.
Mirna Therapeutics Inc. is a clinical-stage biopharmaceutical company. The company is engaged in the development of microRNA-based oncology therapeutics. The company’s lead product candidate is designed to mimic the natural occurring microRNA tumor suppressor miR-34.
Ticker Symbol: MIRN (NASDAQ)
Company Website: www.mirnatherapeutics.com
Social Media: Mirna Therapeutics LinkedIn
Headquarters: Austin, TX